ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ... Oct 16
Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections... Oct 08
-Advertisements-